The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

Adolescents in the United States with symptoms of ADHD had a higher likelihood of using tobacco and other nicotine-based ...

The American Heart Association and American College of Cardiology issued a scientific statement detailing clinical guidance ...

Most adults in the United States with physical chronic health conditions manage them at work but have not told their employer ...

As we approach the first anniversary of omalizumab’s approval for food allergy, its use is “definitely going to grow,” Robert ...

This is a developing news story. Please check back soon for updates. Seonix Bio launched SightScore, a polygenic risk score ...

The presentation of Cushing’s disease varies by age, with older adults having fewer hallmark features of the condition and ...

Paxlovid may not decrease the risk for hospitalization or death in older adults vaccinated against COVID-19 as much as ...

The investigational new drug application for Zabalafin Hydrogel for the treatment of mild to moderate atopic dermatitis has ...

The latest data from The Vision Council’s Market inSights report indicate that the proportion of contact lenses and glasses ...

The FDA has approved Ctexli for the treatment of cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease, in ...

Researchers’ understanding of the pathogenesis of rheumatoid arthritis has grown considerably in recent years, laying the ...